NanoZymeX
N
Active
Developing a lipid nanoparticle platform for enhanced enzyme replacement therapy.
NanoZymeX
Developing a lipid nanoparticle platform for enhanced enzyme replacement therapy.
About
NanoZymeX is a biotech startup spun out of research at the University of Basel. The company is developing a novel platform utilizing lipid nanoparticles to improve enzyme replacement therapies for rare genetic conditions, such as Pompe disease. Their technology aims to enhance the delivery of therapeutic enzymes into target cells and lysosomes, thereby increasing therapeutic activity in affected tissues and reducing immune responses to repeated treatments. The platform is designed to improve existing enzyme therapies and can be adapted to multiple lysosomal storage disorders. NanoZymeX plans to partner with pharmaceutical and biotechnology companies to bring next-generation enzyme therapies to patients.
Tags
Performance
Company Timeline
No timeline data for this period
Score Breakdown
10Traction
26Team
30Visibility
18Profile
0Community
0Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does NanoZymeX do?
NanoZymeX is a biotech startup spun out of research at the University of Basel. The company is developing a novel platform utilizing lipid nanoparticles to improve enzyme replacement therapies for rare genetic conditions, such as Pompe disease. Their technology aims to enhance the delivery of therapeutic enzymes into target cells and lysosomes, thereby increasing therapeutic activity in affected tissues and reducing immune responses to repeated treatments. The platform is designed to improve exi…
How much funding has NanoZymeX raised?
NanoZymeX has raised a total of $160K in funding. The most recent round on record is Pre-Seed.
Where is NanoZymeX headquartered?
NanoZymeX is headquartered in Basel, Switzerland.
What industry does NanoZymeX operate in?
NanoZymeX operates in Biotechnology, Rare Diseases, Drug Delivery, Therapeutics.